Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Auteurs : Woff E, Salvatore L, Marmorino F, Genovesi D, Critchi G, Guiot T, Ameye L, Sclafani F, Hendlisz A, Flamen P
Jaar : 2022
Journal : J Nucl Med
Volume : 63
Pagina's : 549-555

Sarcoidosis Versus Lymphoma?

Auteurs : Dal Lago L, Sarrand J, Woff E, Awada A, Vouche M, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002250

Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CT.

Auteurs : Plouznikoff N, Artigas C, Woff E, Ene D, Flamen P
Jaar : 2020
Journal : Clin Nucl Med
Volume : 45
Pagina's : 459-460

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.

Auteurs : Camera S, Akin Telli T, Woff E, Vandeputte C, Kehagias P, Guiot T, Critchi G, Wissam Y, Bregni G, Trevisi E, Pretta A, Senti C, Leduc S, Gkolfakis P, Hoerner F, Rothé F, Sclafani F, Flamen P, Deleporte A, Hendlisz A
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate Cancer.

Auteurs : Plouznikoff N, Woff E, Artigas C, Alexiou J, Flamen P
Jaar : 2019
Journal : Clin Nucl Med
Volume : 44
Pagina's : e501-e502

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Auteurs : Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P
Jaar : 2019
Journal : J Nucl Med
Volume : 60
Pagina's : 178-184

Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Auteurs : Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P
Jaar : 2019
Journal : J Nucl Med
Volume : 60
Pagina's : 1366-1372

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.

Auteurs : Woff E, Hendlisz A, Garcia C, Deleporte A, Delaunoit T, Maréchal R, Holbrechts S, Van den Eynde M, Demolin G, Vierasu I, Lhommel R, Gauthier N, Guiot T, Ameye L, Flamen P
Jaar : 2016
Journal : Eur J Nucl Med Mol Imaging
Volume : 43(10)
Pagina's : 1792-801

Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].

Auteurs : Bron D, de Wind R, Cantinieaux B, Woff E, Roelandts M, Moerman C, Lemort M, Heimann P, de Wilde V, Meuleman N, Maerevoet M
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 237-47